Surveillance of Hepatocellular Carcinoma Post Intervention with Primovist Enhanced MRI: Comparison with MDCT: A Case Presentation
Manish Kumar Shah, Deng Gang*
Department of Vascular and Interventional Radiology, The Affiliated Zhongda Hospital of Southeast University, Nanjing 210009, China.
Surveillance of hepatocellular carcinoma has significantly increased life expectancy inpatient already diagnosed with hepatocellular carcinoma (HCC) with the addition of new hepato-specific contrast along with powerful magnetic resonance imaging (MRI). This combination has significantly improved the detection of the new, recurrent and residual lesion. This is a case report of a 40-year-old Chinese female with primary liver cancer treated with liver resection. Space occupying lesions of the liver was detected for which she also underwent trans-catheter arterial chemoembolization (TACE) at The People's Liberation Army No. 81 Hospital, Nanjing, China. In our case report, the surveillance was possible through the use of 3T MRI with PrimovistTM, which revealed a new HCC lesion and the patient, was later planned for TACE.